You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 19, 2025

Details for Patent: 10,683,499


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,683,499
Title:Compositions and methods for modulating TTR expression
Abstract:Provided herein are oligomeric compounds with conjugate groups. In certain embodiments, the oligomeric compounds are conjugated to N-Acetylgalactosamine.
Inventor(s):Prakash Thazha P., Seth Punit P., Swayze Eric E.
Assignee:Ionis Pharmaceuticals, Inc.
Application Number:US15687306
Patent Claim Types:
see list of patent claims
 
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 10,683,499: A Comprehensive Guide

Introduction

Understanding the scope and claims of a patent is crucial for inventors, researchers, and businesses to navigate the complex landscape of intellectual property. This article will delve into the details of United States Patent 10,683,499, titled "Compositions and methods for modulating TTR expression," and provide a thorough analysis of its scope, claims, and the broader patent landscape.

Overview of the Patent

United States Patent 10,683,499, issued to Ionis Pharmaceuticals, pertains to compositions and methods for modulating the expression of transthyretin (TTR), a protein associated with various diseases, including amyloidosis and familial amyloid polyneuropathy[4].

Scope of the Patent

The scope of a patent defines the boundaries of what is protected by the patent. For US Patent 10,683,499, the scope includes:

Compositions

The patent covers specific oligomeric compounds, particularly those conjugated to N-Acetylgalactosamine, designed to modulate TTR expression. These compositions are tailored to target the liver, where TTR is primarily produced, and other tissues such as the choroid plexus in the brain[4].

Methods

The patent also encompasses methods for using these compositions to reduce TTR levels. This includes administration routes, dosages, and treatment regimens aimed at managing TTR-related diseases.

Claims of the Patent

The claims section of a patent is critical as it defines the legal boundaries of the invention. Here are some key aspects of the claims in US Patent 10,683,499:

Independent Claims

Independent claims are standalone and do not rely on other claims. For this patent, independent claims typically describe the novel compositions and their use in treating TTR-related conditions.

Dependent Claims

Dependent claims build upon independent claims and provide additional specificity. These might include specific conjugate groups, administration methods, or patient populations.

Claim Structure

The claims are structured to ensure broad protection while maintaining specificity. For example, Claim 1 might describe a broad composition, while subsequent claims narrow down to specific embodiments, such as particular conjugate groups or dosing regimens[4].

Prior Art and Novelty

To be patentable, an invention must be novel and non-obvious. The prior art section of the patent application and the issued patent highlights existing knowledge in the field that the inventors have built upon.

Prior Art Keywords

Keywords such as "modified oligonucleotide," "nucleoside," and "compound" indicate the areas of prior art that the inventors have considered and differentiated their work from[4].

Patent Landscape

Understanding the broader patent landscape is essential for navigating potential infringement issues and identifying opportunities for innovation.

Global Dossier and International Patent Offices

The Global Dossier service provided by the USPTO allows users to view the file histories of related applications from participating IP Offices, which can help in understanding how similar patents have been treated globally[1].

Related Patents

Other patents related to TTR modulation, such as WO-2010017509-A1, provide insights into the competitive landscape and potential areas for further innovation. These patents may cover different aspects of TTR modulation, such as targeting different tissues or using alternative compositions[5].

Search Tools and Resources

Several tools and resources are available to help in searching and analyzing patents:

Patent Public Search

The USPTO's Patent Public Search tool offers enhanced access to prior art and is a valuable resource for conducting thorough patent searches[1].

Common Citation Document (CCD)

The CCD application consolidates citation data from multiple IP Offices, making it easier to visualize the prior art landscape for a particular invention[1].

Patent and Trademark Resource Centers (PTRCs)

Local PTRCs provide training and resources for patent searching, which can be particularly useful for those new to patent research[1].

Economic and Research Implications

The Patent Claims Research Dataset provided by the USPTO offers detailed information on claims from U.S. patents, including those related to biotechnology and pharmaceuticals. This dataset can help in analyzing trends and the scope of patent claims over time[3].

Patent Scope Measurements

Research papers such as "Patent Claims and Patent Scope" by Marco, Sarnoff, and deGrazia provide insights into measuring patent scope, which can be applied to understand the breadth and depth of protection offered by patents like US 10,683,499[3].

Legal Status and Expiration

The legal status of a patent, including its expiration date, is crucial for understanding the current and future landscape of intellectual property rights. US Patent 10,683,499 is currently active but will expire based on its filing and grant dates[4].

Conclusion

Understanding the scope and claims of US Patent 10,683,499 is vital for anyone involved in TTR-related research or development. By leveraging the resources provided by the USPTO and other international patent offices, one can navigate the complex patent landscape effectively.

Key Takeaways

  • Compositions and Methods: The patent covers specific oligomeric compounds and methods for modulating TTR expression.
  • Claims Structure: Independent and dependent claims define the legal boundaries of the invention.
  • Prior Art: The patent differentiates itself from existing knowledge in the field.
  • Patent Landscape: Global Dossier and related patents provide insights into the competitive landscape.
  • Search Tools: Resources like Patent Public Search and CCD are essential for thorough patent searches.
  • Economic Implications: The Patent Claims Research Dataset helps in analyzing trends in patent claims.

FAQs

What is the main subject of US Patent 10,683,499?

The main subject is compositions and methods for modulating transthyretin (TTR) expression.

How can I search for related patents globally?

Use the Global Dossier service and search databases from international patent offices like the EPO, JPO, and WIPO[1].

What tools are available for patent searching?

Tools include the Patent Public Search, Common Citation Document (CCD), and resources from Patent and Trademark Resource Centers (PTRCs)[1].

How do I determine the legal status of a patent?

Check the patent's details on the USPTO website or through the Patent Public Search tool[1].

What is the significance of the Patent Claims Research Dataset?

It provides detailed information on claims from U.S. patents, helping in analyzing trends and scope of patent claims over time[3].

Where can I find more information on patent scope measurements?

Refer to research papers such as "Patent Claims and Patent Scope" by Marco, Sarnoff, and deGrazia[3].

Sources

  1. USPTO - Search for patents: https://www.uspto.gov/patents/search
  2. Ionis Pharmaceuticals - Patent Details: https://ir.ionis.com/static-files/57b8b6db-9f04-43b1-ac4e-163694c318fa
  3. USPTO - Patent Claims Research Dataset: https://www.uspto.gov/ip-policy/economic-research/research-datasets/patent-claims-research-dataset
  4. Google Patents - US10683499B2: https://patents.google.com/patent/US10683499B2/en
  5. Unified Patents Portal - WO-2010017509-A1: https://portal.unifiedpatents.com/patents/patent/WO-2010017509-A1

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 10,683,499

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Astrazeneca Ab WAINUA (AUTOINJECTOR) eplontersen sodium SOLUTION;SUBCUTANEOUS 217388-001 Dec 21, 2023 RX Yes Yes 10,683,499 ⤷  Try for Free Y Y TREATMENT OF POLYNEUROPATHY OF HEREDITARY TRANSTHYRETIN-MEDIATED AMYLOIDOSIS ⤷  Try for Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 10,683,499

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2014259750 ⤷  Try for Free
Australia 2014259755 ⤷  Try for Free
Australia 2014259756 ⤷  Try for Free
Australia 2014259757 ⤷  Try for Free
Australia 2014259759 ⤷  Try for Free
Australia 2017200365 ⤷  Try for Free
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.